InvestorsHub Logo
Followers 800
Posts 50862
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Wednesday, 05/20/2015 8:28:18 AM

Wednesday, May 20, 2015 8:28:18 AM

Post# of 1250
NEWS >>> PlasmaTech Biopharma Gets FDA Designations for ABX-101 and ABX-102 for Sanfilippo Syndromes *Wednesday 05/20/2015 08:03 AM ET - Dow Jones News

PlasmaTech Biopharmaceuticals Announces Orphan Drug, Rare Pediatric Disease Designations From FDA *Wednesday 05/20/2015 08:03 AM ET - Dow Jones News

PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDAWednesday 05/20/2015 08:03 AM ET - MarketWire via Dow Jones News
PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA Two FDA Designations for Both ABX-101 and ABX-102 for Sanfilippo Syndromes (MPS IIIA

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABEO News